Clik here to view.
Mayne Pharma Acquires Rights to a Portfolio of Dermatology Foam Products...
GREENVILLE, N.C. Mayne Pharma (ASX: MYX) is pleased to announce it has acquired a portfolio of on-market dermatology Foam Assets from GSK for US$50.1 million. The Foam Assets include US rights to...
View ArticleClik here to view.
ピラマル・エンタープライゼズが高活性原薬（HPAPI）の米国CDMOアッシュ・スティーブンスを買収する契約を締結
印ムンバイ （ビジネスワイヤ） — ピラマル・エンタープライゼズ・リミテッド (PEL、NSE: PEL、BSE:...
View ArticleClik here to view.
Masimo宣布用于呼吸速率rainbow Acoustic Monitoring®的RAS-45传感器获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，用于呼吸速率(RRa®) rainbow Acoustic Monitoring® (RAM™)的单用成人及儿科声学呼吸传感器RAS-45获得标记。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
マシモが呼吸数測定のrainbow アコースティックモニタリング用のRAS-45センサーでCEマークを取得したと発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、単回使用の成人／小児用アコースティック呼吸センサーRAS-45でCEマークを取得したと発表しました。RAS-45は呼吸数（RRa®）を測定するrainbow アコースティックモニタリング（RAM™）に使用するものです。 このSmart News...
View ArticleClik here to view.
Daiichi Sankyo Selects Veeva Vault to Streamline Submissions, eTMF, and...
PLEASANTON, Calif. & TOKYO Veeva Systems (NYSE:VEEV) today announced that Daiichi Sankyo Company, Limited (hereinafter, Daiichi Sankyo) based in Japan, selected Veeva Vault eTMF, Veeva Vault...
View ArticleClik here to view.
SAB Biotherapeutics Announces Contract with BARDA to Advance First MERS...
SIOUX FALLS, S.D. SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company, announced today that it has been awarded a contract for up to $5.3 million by the...
View ArticleClik here to view.
武田薬品: 医薬品アクセス（Access to Medicines）に関する新たな取り組みについて
大阪 （ビジネスワイヤ） — 当社は、このたび、アンメットメディカルニーズの高い患者さんを対象に、生命を救う可能性のある当社の革新的な医薬品に対するアクセスを改善することを目的として、医薬品アクセス（Access to...
View ArticleClik here to view.
Takeda Announces Bold, New Access to Medicines Strategy
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and...
View ArticleClik here to view.
SciBase: New Study: Swedish Nevisense Can Reduce Follow-up Visits by Half for...
STOCKHOLM SciBase (STO:SCIB) A new Australian study, using the Swedish instrument Nevisense, showed it is possible to reduce the number of cases that require digital dermoscopy follow-up by almost...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Launches Nitroglycerin Sublingual Tablets USP in the...
HYDERABAD, India & PRINCETON, NJ Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and...
View ArticleClik here to view.
OvaScience’s AUGMENT Treatment Commercially Available in Japan Through...
WALTHAM, Mass. OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that it has finalized its...
View ArticleClik here to view.
Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to...
TOKYO Nichi-Iko Pharmaceutical Co., Ltd. (TSE:4541) (“Nichi-Iko” or “Parent”) today announced the results of its tender offer to purchase all of the outstanding shares of common stock of Sagent...
View ArticleClik here to view.
ZRG Partners Releases Q2 2016 Global Life Sciences Hiring Index
ROCHELLE PARK, N.J. ZRG Partners has announced the findings for the second quarter Global Life Sciences Hiring Index. 2016 has shown an increase in hiring demand consistently, posting 50% higher...
View ArticleClik here to view.
Masimo Announces Four-Year Partnership with World Federation of Societies of...
IRVINE, Calif. & HONG KONG Masimo (NASDAQ: MASI) announced Sunday at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World...
View ArticleClik here to view.
武田发布宏伟的全新药品获取战略
日本大阪 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)今天宣布启动一项宏伟的全新药品获取(Access to Medicines, AtM)战略，旨在使面临部分最紧迫的未获满足医疗需求的患者增加获取有望挽救生命的武田创新药品。数十年来，该公司依据地区性的需求，已在世界许多地方提供产品、经费和获取。新的AtM战略以此为基础，专注于面临最紧迫的未获满足需求的地区和治疗领域。...
View ArticleClik here to view.
Masimo发布针对寨卡病毒肆虐地区总血红蛋白(SpHb®)监测的特别全球项目
加州尔湾 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，为了回应寨卡病毒及其对血制品可及性的潜在影响，Masimo正在创立一个特别项目，以大幅降低 Masimo的连续血红蛋白监测(SpHb®)解决方案的成本、增加其获取，研究显示，该方案可帮助临床医生减少低失血量和高失血量手术中的输血量。该特别项目将适用于血液供应受寨卡病毒影响的所有地区。...
View ArticleClik here to view.
GORE® DrySeal Flex Introducer Sheath Advances Care through Access
FLAGSTAFF, Ariz. W. L. Gore & Associates, Inc. (Gore) today announced the commercial availability of the GORE® DrySeal Flex Introducer Sheath, after recently gaining clearance for use by...
View ArticleClik here to view.
Masimo宣布与世界麻醉师学会联盟(WFSA)缔结为期4年的伙伴关系
加州尔湾和香港 (美国商业资讯) — Masimo (NASDAQ: MASI)星期天在香港召开的世界麻醉师大会(WCA)上宣布，该公司已成为世界麻醉师学会联盟(WFSA)的首个全球影响伙伴。该伙伴关系名为“Safe Anaesthesia – ASAP”（麻醉安全行动计划），首先将确定一个难以获取安全麻醉的国家，然后协同落实一些旨在改善麻醉医护和安全手术转归的项目和培训。...
View ArticleClik here to view.
GORE® DrySeal Flex Introducer Sheathはアクセス改善で治療を前進
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、米国・欧州・カナダ・オーストラリアの規制当局から最近承認されたことを受け、GORE® DrySeal Flex Introducer...
View ArticleClik here to view.
GORE® DrySeal Flex导引器套管可简化路径以促进治疗
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，GORE® DrySeal Flex导引器套管最近已获得美国、欧洲、加拿大和澳大利亚监管部门的核准，开始市售。该器械旨在凭借提升的弯曲度、抗扭曲性和亲水涂层的独特组合，来简化血管内修复手术期间至高难度解剖部位和旁支血管（例如髂总动脉）的路径。 Smart...
View Article